CRL · 8-K · 20260924PR000142
Guidance and Outlook
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-09-24 · Importance 58 · Surprise 32 · In source text
Charles River reaffirmed its 2026 financial guidance and expects revenue and non-GAAP earnings per share at the upper ends of their respective ranges, primarily reflecting continued favorable demand from biopharmaceutical clients. The 2026 ranges include 0%–1% organic revenue growth, a 21.0%–21.3% non-GAAP operating margin, and non-GAAP EPS of $11.15–$11.45. Through 2030, the company targets 5%–7% organic revenue growth CAGR for 2027–2030, approximately 24% non-GAAP operating margin, and low-double-digit non-GAAP EPS CAGR for 2027–2030. The long-term targets exclude the impact of future acquisitions or divestitures.
Key facts
- Charles River's 2030 organic revenue growth target is 5%–7% CAGR from 2027 through 2030. source
- Charles River's 2030 non-GAAP EPS target is low-double-digit CAGR from 2027 through 2030. source
- Charles River expects 2026 revenue and non-GAAP earnings per share to be at the upper ends of their respective guidance ranges, primarily reflecting continued favorable demand from biopharmaceutical clients. source
- Charles River's 2026 organic revenue growth guidance is at the upper end of the 0%–1% growth range. source
- Charles River's 2026 non-GAAP operating margin guidance is 21.0%–21.3%. source
- Charles River's 2026 non-GAAP earnings per share estimate is at the upper end of $11.15–$11.45. source
- Charles River's 2030 non-GAAP operating margin target is approximately 24%. source
- Charles River's financial targets through 2030 do not include the impact of future acquisitions or divestitures. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +5.1% | Charles River's 2030 organic revenue growth target is 5%–7% CAGR from 2027 through 2030. |
| revenue | positive | committed | +0.8% | Charles River's 2026 organic revenue growth guidance is at the upper end of the 0%–1% growth range. |
| net_income | positive | committed | — | Charles River's 2030 non-GAAP EPS target is low-double-digit CAGR from 2027 through 2030. |
| margin | unclear | committed | — | Charles River's 2026 non-GAAP operating margin guidance is 21.0%–21.3%. |
| net_income | positive | committed | — | Charles River's 2026 non-GAAP earnings per share estimate is at the upper end of $11.15–$11.45. |
| margin | unclear | committed | — | Charles River's 2030 non-GAAP operating margin target is approximately 24%. |